glp-1 agonists for type 2 diabetes Receptor Agonists: A Game-Changer New Developments in Pharmacological Treatment
Description
A 28-year-old with BMI 29 and no health complications needs a completely different approach than a 45-year-old with BMI 42, Type 2 diabetes, and sleep apnea
doi: 10.1016/j.vph.2018.05.010
Y., Gaspar, S., Deroisy, R., Zegels, B
Treatments must align with metabolic physiology, behavioural science, and sustainable lifestyle adjustments to achieve real, lasting results
Check the National Association of Boards of Pharmacy's online pharmacy verification tool
Nature website
